China is now setting the pace in life sciences R&D, conducting more clinical trials than the U.S. and licensing new ...

Such deals allow Chinese firms to profit while minimising capital outlays, but also carry risks, law firm says.

Under the deal, announced on May 20, Pfizer gains the opportunity to develop and sell the SSGJ-707 drug in markets outside of ...

China is now setting the pace in life sciences R&D, conducting more clinical trials than the U.S. and licensing new ...

Follow along for the latest tariff news, plus live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

Western drugmakers, investors increasingly aim to acquire Chinese compounds.

In this era of escalating trade tensions and geopolitical uncertainty, the U.S. cannot afford to cede another critical ...

TCG Labs Soleil’s Juri Biosciences is offering EpimAb Biotherapeutics up to $210 million biobucks for exclusive licensing ...

CPHI & PMEC China will be returning to the Shanghai New International Expo Center from June 24-26 amid a marked surge in international interest, with industry momentum rebounding following a string of ...

Pharma company stocks tumbled after Donald Trump announced a plan to reduce U.S. drug prices, but regained some ground on belief the plan would be hard to implement Drug prices are expected to decline ...